Skip to main content
Equibles

MORGAN STANLEY

Position in NBP — NovaBridge Biosciences

CIK 895421 NEW YORK, NY
Back to NBP Full portfolio

Position in NBP

as of Jun 30, 2026 · filed Aug 13, 2026
Position Value
$7,123,793
-$2,318,173 QoQ
Shares Held
3,653,228
-4.8% QoQ
Ownership
3.16%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#2
of 49 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in NBP Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Jun 30, 2026

MORGAN STANLEY holds $16,838,649,954 across 523 Biotechnology names. NBP ranks #154 (0.0% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 RPRX
Royalty Pharma plc
 42,931,597 $2,407,174,637
2 VRTX
Vertex Pharmaceuticals Inc / Ma
 3,242,139 $1,610,467,694
3 ROIV
Roivant Sciences Ltd.
 42,592,905 $1,507,362,901
4 REGN
Regeneron Pharmaceuticals, Inc.
 1,397,712 $871,529,332
5 MRNA
Moderna, Inc.
 9,538,094 $667,952,718
6 ARGX
Argenx SE
 643,123 $596,670,219
7 TECH
BIO-TECHNE Corp
 6,374,717 $450,373,747
8 INCY
Incyte Corp
 2,948,364 $334,226,536

All Filings in NBP

Export CSV
26 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $7,123,793 3,653,228
2026-03-31 $9,441,966 3,838,198
2025-12-31 $15,066,295 3,785,502
2025-09-30 $8,437,109 2,232,040
2025-06-30 $141,073 58,295
2025-03-31 $28,688 34,817
2024-12-31 $3,011,875 3,543,384
2024-09-30 $38,001 30,647
2024-06-30 $23,177 13,880
2024-03-31 $18,800 10,109
2023-12-31 $981,722 516,696
2023-09-30 $1,305,057 988,681
2023-06-30 $1,328,126 444,190
2023-03-31 $3,858,492 1,115,172
2022-12-31 $6,651,509 1,591,271
2022-09-30 $7,590,142 1,892,804
2022-06-30 $26,848,436 2,375,968
2022-03-31 $26,380,384 1,624,408
2021-12-31 $69,111,489 1,458,356
2021-09-30 $103,937,029 1,433,812
2021-06-30 $39,628,344 472,047
2021-03-31 $11,211,400 231,306
2020-12-31 $8,922,477 189,236
2020-09-30 $7,607,242 161,753
2020-06-30 $5,241,610 175,129
2020-03-31 $2,275,000 175,000